Saurabh Saha, Centessa CEO (BIO19)
One of 2021's star biotech players flags another big setback for the pipeline
Two months after scuttling their lead drug, Centessa’s executive team is back with the latest in a series of setbacks that have tanked its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
